FI19992648A - Lääkkeen luovutuslaitteita ja menetelmiä virus- ja mikrobi-infektioiden ja riutumissyndrooman hoitoon - Google Patents

Lääkkeen luovutuslaitteita ja menetelmiä virus- ja mikrobi-infektioiden ja riutumissyndrooman hoitoon

Info

Publication number
FI19992648A
FI19992648A FI992648A FI19992648A FI19992648A FI 19992648 A FI19992648 A FI 19992648A FI 992648 A FI992648 A FI 992648A FI 19992648 A FI19992648 A FI 19992648A FI 19992648 A FI19992648 A FI 19992648A
Authority
FI
Finland
Prior art keywords
viral
treatment
methods
drug delivery
delivery devices
Prior art date
Application number
FI992648A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Michelle Olga Patricia Visser
Original Assignee
Cryopreservation Tech Cc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Cryopreservation Tech Cc filed Critical Cryopreservation Tech Cc
Publication of FI19992648A publication Critical patent/FI19992648A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FI992648A 1997-06-13 1999-12-09 Lääkkeen luovutuslaitteita ja menetelmiä virus- ja mikrobi-infektioiden ja riutumissyndrooman hoitoon FI19992648A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
FI19992648A true FI19992648A (fi) 2000-02-03

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
FI992648A FI19992648A (fi) 1997-06-13 1999-12-09 Lääkkeen luovutuslaitteita ja menetelmiä virus- ja mikrobi-infektioiden ja riutumissyndrooman hoitoon

Country Status (34)

Country Link
EP (1) EP1011567A4 (ko)
JP (1) JP4531141B2 (ko)
KR (1) KR20010013709A (ko)
CN (1) CN1260703A (ko)
AP (1) AP1629A (ko)
AR (1) AR012970A1 (ko)
AU (1) AU7831598A (ko)
BG (1) BG103997A (ko)
BR (1) BR9810095A (ko)
CA (1) CA2295176A1 (ko)
CZ (1) CZ298510B6 (ko)
EA (1) EA200000011A1 (ko)
EE (1) EE9900562A (ko)
ES (1) ES2161187B1 (ko)
FI (1) FI19992648A (ko)
GB (1) GB2341319B (ko)
HU (1) HUP0003034A2 (ko)
ID (1) ID23516A (ko)
IL (2) IL133396A0 (ko)
IS (1) IS5289A (ko)
LT (1) LT4714B (ko)
LV (1) LV12490B (ko)
NO (1) NO996117L (ko)
NZ (1) NZ501669A (ko)
OA (1) OA11307A (ko)
PL (1) PL196256B1 (ko)
RO (1) RO121252B1 (ko)
SI (1) SI20191A (ko)
SK (1) SK172299A3 (ko)
TN (1) TNSN98086A1 (ko)
TR (1) TR200000540T2 (ko)
WO (1) WO1998056325A1 (ko)
YU (1) YU66099A (ko)
ZA (1) ZA984649B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
WO1993016992A1 (en) * 1992-02-20 1993-09-02 Merrell Dow Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
SI9620126A (sl) * 1995-12-15 1999-10-31 Cryopreservation Technologies Cc (Za/Za) Spojina za kriogensko ohranjanje organov in zdravljenje virusnih ter bakterijskih infekcij

Also Published As

Publication number Publication date
HUP0003034A2 (hu) 2000-12-28
YU66099A (sh) 2002-10-18
GB2341319B (en) 2002-02-27
KR20010013709A (ko) 2001-02-26
LT99148A (en) 2000-07-25
PL196256B1 (pl) 2007-12-31
LT4714B (lt) 2000-10-25
CN1260703A (zh) 2000-07-19
ES2161187A1 (es) 2001-11-16
WO1998056325A1 (en) 1998-12-17
PL338439A1 (en) 2000-11-06
IL133396A0 (en) 2001-04-30
TR200000540T2 (tr) 2000-09-21
IS5289A (is) 1999-12-08
CZ9904473A3 (cs) 2001-03-14
NZ501669A (en) 2001-09-28
CA2295176A1 (en) 1998-12-17
NO996117D0 (no) 1999-12-10
IL133396A (en) 2006-10-05
AP9901708A0 (en) 1999-12-31
ZA984649B (en) 1999-12-17
TNSN98086A1 (fr) 2005-03-15
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
EA200000011A1 (ru) 2000-08-28
NO996117L (no) 2000-02-11
AR012970A1 (es) 2000-11-22
JP4531141B2 (ja) 2010-08-25
ES2161187B1 (es) 2003-08-16
SI20191A (sl) 2000-10-31
GB9929189D0 (en) 2000-02-02
EE9900562A (et) 2000-06-15
AP1629A (en) 2006-07-11
EP1011567A1 (en) 2000-06-28
LV12490B (en) 2000-12-20
EP1011567A4 (en) 2000-06-28
AU7831598A (en) 1998-12-30
JP2002511862A (ja) 2002-04-16
BG103997A (en) 2001-07-31
CZ298510B6 (cs) 2007-10-24
SK172299A3 (en) 2000-09-12
GB2341319A (en) 2000-03-15
LV12490A (en) 2000-06-20
ID23516A (id) 2000-04-27
BR9810095A (pt) 2001-11-13

Similar Documents

Publication Publication Date Title
DE60039626D1 (de) Vorrichtungen zur verabreichung von arzneistoffen mit antiprogestinischen eigenschaften
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
NO994837L (no) Intravesikal medikamentavleveringssystem
DE69832298D1 (de) Gerät zur kontrollierten abgabe von pharmazeutischen und medizinischen produkten
EE9900453A (et) Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid
DE60043305D1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69733994D1 (de) Sauger zur medikamentenverabreichung
DE69823583D1 (de) Kassette und Kassetenliefersystem
DK0907358T3 (da) Behandling med ensartet afgivelse af lægemiddel
EE200200160A (et) 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid
FI963883A (fi) Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi
NO20005179D0 (no) Medikament behandling
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
FI973185A (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
FI965114A0 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
FI19992648A (fi) Lääkkeen luovutuslaitteita ja menetelmiä virus- ja mikrobi-infektioiden ja riutumissyndrooman hoitoon
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
DE69934902D1 (de) Medikament gegen drogenabhängigkeit
EP1143990A3 (en) Pharmaceutical compostions comprising peg-asparaginase for the treatment of hiv infections
AU4145999A (en) Topical drug for the treatment of viral infections
NO20013939D0 (no) Behandling av kroniske virusinfeksjoner med M. vaccae
NO20013464D0 (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
BR9400411A (pt) Medicamento para tratamento de dilacerações traumatismos infecções deversas e assepsias